β2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain
- 1 July 2008
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 6 (7), 1215-1223
- https://doi.org/10.1111/j.1538-7836.2008.03000.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosisBlood, 2005
- Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesisCytokine & Growth Factor Reviews, 2005
- Domain V of β2-Glycoprotein I Binds Factor XI/XIa and Is Cleaved at Lys317-Thr318Published by Elsevier BV ,2005
- Nicked 2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysisBlood, 2004
- Beta 2 glycoprotein I-function in health and diseaseThrombosis Research, 2004
- Angiogenesis in health and diseaseNature Medicine, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Epitope Studies with Anti-β2-glycoprotein I Antibodies from Autoantibody and Immunized SourcesJournal of Autoimmunity, 2000
- Anti-β2 glycoprotein I (β2GPI) autoantibodies recognize an epitope on the first domain of β2GPIProceedings of the National Academy of Sciences, 1998
- Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity.Proceedings of the National Academy of Sciences of the United States of America, 1993